By Ben GlickmanEli Lilly said the U.S. Food and Drug Administration had approved Omvoh, its treatment for moderately to severely active ulcerative colitis in adults. The pharmaceutical giant expects the treatment to be available in the U.S. in the coming weeks.

Source: Wall Street Journal October 26, 2023 22:39 UTC